These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 34119765)
41. Cancer cell-derived exosomal LINC00313 induces M2 macrophage differentiation in non-small cell lung cancer. Kong W; Zhang L; Chen Y; Yu Z; Zhao Z Clin Transl Oncol; 2022 Dec; 24(12):2395-2408. PubMed ID: 35980503 [TBL] [Abstract][Full Text] [Related]
42. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783 [TBL] [Abstract][Full Text] [Related]
43. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway. Gao BB; Wang SX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077 [TBL] [Abstract][Full Text] [Related]
44. Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway. Shou Y; Wang X; Chen C; Liang Y; Yang C; Xiao Q; Li H; Wang S; Shu J; Tian X; Chen K Cancer Cell Int; 2022 Apr; 22(1):153. PubMed ID: 35436935 [TBL] [Abstract][Full Text] [Related]
45. Circular RNA circFARSA promotes the tumorigenesis of non-small cell lung cancer by elevating B7H3 via sponging miR-15a-5p. Nie J; Yang R; Zhou R; Deng Y; Li D; Gou D; Zhang Y Cell Cycle; 2022 Dec; 21(24):2575-2589. PubMed ID: 35920698 [TBL] [Abstract][Full Text] [Related]
46. Hypoxic Tumor-Derived Exosomes Induce M2 Macrophage Polarization via PKM2/AMPK to Promote Lung Cancer Progression. Zhou S; Lan Y; Li Y; Li Z; Pu J; Wei L Cell Transplant; 2022; 31():9636897221106998. PubMed ID: 35818293 [TBL] [Abstract][Full Text] [Related]
47. Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3/FABP5 mediated fatty acid oxidation. Lu F; Ye M; Shen Y; Xu Y; Hu C; Chen J; Yu P; Xue B; Gu D; Xu L; Chen L; Ding Y; Bai J; Tian Y; Tang Q Int J Biol Sci; 2024; 20(8):3201-3218. PubMed ID: 38904015 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. Sun B; Hu N; Cong D; Chen K; Li J Bioengineered; 2021 Dec; 12(1):3219-3228. PubMed ID: 34266345 [TBL] [Abstract][Full Text] [Related]
49. The miRNA-21-5p Payload in Exosomes from M2 Macrophages Drives Tumor Cell Aggression via PTEN/Akt Signaling in Renal Cell Carcinoma. Zhang Z; Hu J; Ishihara M; Sharrow AC; Flora K; He Y; Wu L Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328425 [TBL] [Abstract][Full Text] [Related]
50. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells. Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188 [TBL] [Abstract][Full Text] [Related]
51. CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma. Liao W; Du J; Li L; Wu X; Chen X; Feng Q; Xu L; Chen X; Liao M; Huang J; Yuan K; Zeng Y J Exp Clin Cancer Res; 2023 May; 42(1):125. PubMed ID: 37198696 [TBL] [Abstract][Full Text] [Related]
52. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003 [TBL] [Abstract][Full Text] [Related]
53. PTEN/PI3k/AKT Regulates Macrophage Polarization in Emphysematous mice. Lu J; Xie L; Liu C; Zhang Q; Sun S Scand J Immunol; 2017 Jun; 85(6):395-405. PubMed ID: 28273403 [TBL] [Abstract][Full Text] [Related]
54. Inflammatory Periodontal Ligament Stem Cells Drive M1 Macrophage Polarization via Exosomal miR-143-3p-Mediated Regulation of PI3K/AKT/NF-κB Signaling. Wang Y; Zhang X; Wang J; Zhang Y; Ye Q; Wang Y; Fei D; Wang Q Stem Cells; 2023 Mar; 41(2):184-199. PubMed ID: 36520505 [TBL] [Abstract][Full Text] [Related]
55. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732 [TBL] [Abstract][Full Text] [Related]
56. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1. Jin J; Yu G World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096 [TBL] [Abstract][Full Text] [Related]
57. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway. Chen C; Liu Y; Liu L; Si C; Xu Y; Wu X; Wang C; Sun Z; Kang Q J Exp Clin Cancer Res; 2023 Feb; 42(1):46. PubMed ID: 36793126 [TBL] [Abstract][Full Text] [Related]
58. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. Guo Y; Cui J; Liang X; Chen T; Lu C; Peng T Int Immunopharmacol; 2024 Jan; 127():111407. PubMed ID: 38134594 [TBL] [Abstract][Full Text] [Related]
59. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer. Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421 [TBL] [Abstract][Full Text] [Related]
60. [Effect of exosome-derived miR-223 from macrophages on the metastasis of gastric cancer cells]. Zheng PM; Gao HJ; Li JM; Zhang P; Li G Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(22):1750-1755. PubMed ID: 32536099 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]